Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100046962Phase 4Completed
Phase 4 trial of ulinastatin in asphyxia neonatorum (2 arms), sponsored by People's Hospital of Wuhan University. Primary endpoints: Serum IL-6 level, Serum S100β protein level and 1 more. Started Jan 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100046962.